QTTB · Q32 Bio Inc
United States · RS rating 68 · As of 2026-11-03
| Price | 8.76 USD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 70 / 10 / 97 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 35 / 50 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | +18.5% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +59.0% |
| Market cap (USD) | $94.8M |